The overburdened airports will be difficult to improve, while the city's hotel stock is so run down though still high-priced that Olympics fans will stay in cruise ships.
In fact, the Cowen analysts say, the last stock to outperform after its FDA launch was Alexion, the maker of the high-priced orphan drug Soliris, in 2007.
For those investors that can get out of their bunkers to do some stock picking, you might want to go for some high-quality, low-priced dividend stocks that will pay you to own them.